Synonym |
H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro |
Species |
N/A |
Protein Accession |
N/A |
Purity |
N/A |
Endotoxin Level |
N/A |
Biological Activity |
N/A |
Expression System |
N/A |
Fusion Tag |
N/A |
Predicted Molecular Mass |
N/A |
Formulation |
N/A |
Reconstitution |
N/A |
Storage & Stability |
N/A |
FAQ
What is the primary application of H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro in scientific
research?
H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro is a synthetic peptide that plays a
significant role in various biochemical and biophysical research fields, specifically those focused on
enzymology and molecular interaction studies. This peptide is of particular interest due to its labeled
N-terminus with EDANS (5-((2-aminoethyl)amino)naphthalene-1-sulfonic acid), a fluorescent probe that
allows researchers to monitor molecular interactions and conformational changes in real-time. This
fluorescence capability is particularly vital in studies involving the analysis of enzymatic activities,
especially those that involve proteolytic enzymes. When used in FRET (Förster Resonance Energy Transfer)
assays, the peptide serves as an excellent substrate for examining enzyme activity, whereby cleavage of
the peptide results in a measurable change in fluorescence which can be correlated to enzyme kinetics
and efficiency.
This peptide is also advantageous because it aids in understanding
protein-protein interactions in cell biology. Researchers employ
H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro to study how proteins interact under various
conditions, thus providing insights into the dynamics of cellular processes. Moreover, it can be used in
the quantitative determination of peptide cleavage speed and pattern, paving the way for the discovery
of specific inhibitors that may be utilized in therapeutic interventions. The precision with which it
assists in measuring interaction dynamics makes it indispensable in drug discovery programs, especially
when determining the impact of small molecular ligands on protein conformation.
Furthermore, the
peptide’s structure based on its amino acid sequence allows it to serve as a model for investigating the
effects of amino acid modifications and substitutions on the stability and function of protein
structures. Researchers interested in protein folding and misfolding, for instance, can use this peptide
to simulate interactions and analyze the impact of pathological conditions that involve protein
aggregation, as seen in diseases like Alzheimer’s and Parkinson’s. The customizable nature of the
peptide sequence offers potential for tailored experimental frameworks, wherein additional modifications
may be introduced to study specific biological reactions.
How can
H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro contribute to high-throughput screening in drug
discovery?
H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro provides substantial contributions to
high-throughput screening (HTS) processes in drug discovery through its robust application in assays
facilitated by fluorescence-based measurement techniques. The fluorescence emissions of EDANS make the
peptide particularly useful in generating reliable, quantitative data quickly, which is crucial in HTS
settings where vast numbers of compounds are screened simultaneously. The sensitivity of the fluorescent
signal emitted by the EDANS moiety allows researchers to detect minimal alterations in peptide cleavage
or interaction, which is particularly advantageous when screening for enzyme inhibitors, agonists, or
antagonists.
The utilization of this peptide in HTS is made more efficient because its cleavage
by specific enzymes can be continuously monitored, providing rapid and real-time assessment of enzymatic
activity and inhibition. The availability of such detailed kinetic information immediately reveals
active compounds that may exhibit potential medicinal properties, thus streamlining the drug development
process. Essentially, this fluorescence-based readout of enzyme activity can highlight alterations in
activity brought about by potential drug candidates, thereby providing early insights into their
efficacy and potential side effects.
Moreover, the peptide can be adapted to simulate
interactions found within natural biological systems, allowing for the assessment of compound
interactions in a biologically relevant context. This speaks to the versatility of this peptide in the
drug discovery pipeline, as not only does it help in understanding the immediate effects of potential
drugs, but it can also provide data on the long-term implications of drug usage, including degradation
patterns and secondary interaction pathways.
Importantly, the consistency and reproducibility of
data obtained from using this labeled peptide in HTS highlight its role in maintaining the integrity of
the screening process. By reducing false positives and negatives, researchers can ensure that only the
most promising compounds progress to further stages of drug development. Additionally, the potential to
modify the peptide sequence can lead to the development of specific assays tailored to the enzyme or
interaction of interest, increasing the efficiency and specificity of the HTS process. This makes
H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro not just a tool for immediate applications, but a
foundation for evolving research techniques in drug discovery.
What makes
H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro an effective tool in enzymatic activity
studies?
The effectiveness of H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro in enzymatic
activity studies primarily stems from its intrinsic design as a fluorescent-labeled peptide, which
permits detailed observation and analysis of enzymatic functions. The inclusion of the EDANS fluorescent
moiety at the N-terminus of the peptide is especially beneficial as it acts as a donor in FRET-based
assays. In scenarios where this peptide is used as a substrate for enzymatic reactions, it allows
researchers to monitor the cleavage events and acquire kinetic data by detecting changes in
fluorescence.
This characteristic is instrumental when dissecting complex enzymatic pathways, as
it provides a non-invasive method to study enzyme dynamics over time. The fact that the fluorescence
signal changes upon cleavage by enzymes enables continuous, real-time monitoring of enzymatic processes,
which is pivotal for understanding enzyme specifics, such as reaction rates, substrate specificity, and
inhibition mechanisms. The granularity of data obtainable through such analyses offers deep insights
into biological functions and how various elements within cellular systems interact and coalesce to
drive life processes.
Additionally, the peptide sequence itself, comprising
H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro, is specifically chosen to demonstrate resistance or
susceptibility to various enzymes, making it suitable for a wide range of enzymatic assays. Researchers
leverage this adaptability to assess specific classes of enzymes such as proteases, kinases, and
phosphatases, providing a broad application base for this peptide. By experimenting with different
enzymatic conditions, modifications, and inhibitors, scientists can unveil the nuanced interactions
between the peptide substrate and the enzyme of interest, offering clues into potential modulatory sites
that can be leveraged in designing enzyme inhibitors for therapeutic applications.
Furthermore,
due to its synthesis simplicity and adaptability, the peptide can be modified to incorporate additional
labels or active sites, tailoring it for specific enzyme classes or reaction types. Such flexibility is
crucial for devising new biochemical assays and expanding existing ones to explore emerging scientific
inquiries or test novel hypotheses. These aspects ensure that
H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro remains a valuable, multifaceted tool in enzymatic
studies, contributing to the broader understanding of biochemical pathways and facilitating the
development of innovative strategies for disease intervention.
What advantages does the EDANS
label provide in the context of peptide-based fluorescence assays?
The incorporation of the EDANS
label in peptide-based fluorescence assays offers several compelling advantages that make it a preferred
choice for researchers focused on molecular and biochemical studies. EDANS, or
5-((2-aminoethyl)amino)naphthalene-1-sulfonic acid, is a well-known fluorescent donor used extensively
in FRET (Förster Resonance Energy Transfer) assays. Its utility primarily lies in its ability to serve
as an efficient donor when paired with an appropriate acceptor, such as DABCYL
(4-((4-(dimethylamino)phenyl)azo)benzoic acid), which facilitates the monitoring of peptide cleavage
events. This makes EDANS-labeled peptides highly valuable as substrates for studying enzymatic
activities and protein-protein interactions.
One of the primary benefits of using EDANS in
peptide assays is its capacity for sensitively detecting molecular events via its distinct fluorescence
emission, which can be quantitatively measured. This sensitivity is crucial in assays where detecting
small amounts of cleavage or subtle changes in conformational dynamics is essential. The high quantum
yield and substantial Stokes shift of EDANS allow for strong emission signals that are easily
distinguished against background noise, ensuring the accuracy and reliability of experimental
data.
Moreover, EDANS provides robust versatility in experimental design. Its stability under a
range of physicochemical conditions means researchers can conduct assays across diverse biological
systems without compromising the integrity of the fluorescent signal. This robustness is crucial for
experiments requiring variations in temperature, pH, or ionic strength, as it ensures consistent
performance despite external fluctuations. Additionally, as a part of FRET systems, EDANS facilitates
the study of interactions over relatively large distances, up to 10 nm, allowing for the monitoring of
larger protein or complex formations that are beyond the scope of other techniques.
Beyond its
technical properties, the ability to easily integrate EDANS into peptides or other molecular constructs
provides convenience and flexibility to researchers. This ease of incorporation means that existing
workflows can be adapted with minimal effort, and new assays can be developed rapidly, providing ample
opportunities for innovation in experimental methodologies. The adaptable nature of EDANS also allows
for its use in conjunction with other labeling systems, offering wide-ranging possibilities for complex
experimental setups that require multi-wavelength detection and multiplexing capabilities.
In
summary, the EDANS label enhances peptide-based fluorescence assays by providing high sensitivity,
versatility, and reliability. Its use in FRET-based assays empowers researchers to uncover detailed
insights into enzymatic activities, protein conformational changes, and molecular interactions,
contributing significantly to advancements in biochemical and pharmaceutical research. This makes
EDANS-labeled peptides like H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro invaluable tools for
scientists exploring the intricate dynamics of biological systems.
Why is
H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro preferred in structural and functional studies of
proteins and enzymes?
H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro is preferred in structural
and functional studies of proteins and enzymes due to its strategic design, which facilitates the
detailed examination of biological molecule interactions, enzymatic activities, and protein
conformational states. This synthetic peptide is labeled with the fluorescent probe EDANS, making it an
exceptional tool for real-time monitoring of proteolysis and molecular interactions through fluorescence
assays. The incorporation of EDANS as a donor in fluorescence resonance energy transfer (FRET) assays
allows for the dynamic study of proximity-based changes in biological molecules, critical for
understanding the structure-function relationship in proteins and enzymes.
The preference for
this peptide arises from its ability to serve as both a substrate and a reporter within biochemical
assays. As a substrate, it is cleaved by specific proteolytic enzymes, releasing the EDANS label and
allowing for the observation of enzyme kinetics through changes in fluorescence signals. This provides a
dual advantage: monitoring the cleavage provides insights into specific enzyme mechanisms, and the
degree of fluorescence change offers quantitative data on enzyme activity. Such properties make it
invaluable in the detailed kinetic studies required for biochemical pathway elucidation and drug
discovery processes.
The sequence of this peptide is also significant as it can mimic natural
substrates of various enzymes, enabling studies directly relevant to physiological conditions. By
serving as a proxy, it allows researchers to explore enzymatic processes in a controlled environment,
making it ideal for investigating the regulatory mechanisms of enzymes and evaluating the effects of
potential inhibitors. This is particularly advantageous in pharmaceutical research where understanding
how small molecules interact with or inhibit enzyme activity is critical.
Moreover, the
adaptability of this peptide extends its utility beyond standard assays. By enabling modifications to
the peptide sequence or the incorporation of additional labels, researchers can tailor studies to
examine specific interactions or pathways, enhancing the scope of the research. This ability to
customize assays to suit particular research questions on protein dynamics, folding, and interaction
pathways makes this peptide a preferred choice within molecular biology and biochemical research
circles.
Additionally, the use of this peptide contributes significantly to uncovering structural
dynamics through conformational studies. The fluorescence properties of EDANS facilitate the tracking of
subtle conformational changes that occur when proteins interact or undergo functional transitions. Such
insights are crucial for understanding how proteins achieve their functional conformation and the impact
of mutations on protein stability and function, offering profound implications for therapeutics and
genetic research.
In conclusion, H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro is highly
favored in structural and functional studies due to its fluorescent labeling, versatile application in
enzyme kinetics, adaptability to various research needs, and its role in elucidating deeper biological
interactions. The insights garnered from using this peptide can significantly advance our understanding
of enzymatic and protein functions, furthering research across numerous scientific domains and
applications.